RYTM Rhythm Pharmaceuticals, Inc.
Healthcare$87.84-2.61%ClosedMarket Cap: $6.02B
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$140.20
Target (Median)
$143.00
Target Range
$125.00 - $157.00
Upside from current price: 59.6%
Rating Distribution
4 Strong Buy11 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-07 | Canaccord Genuity | maintain | Buy | Buy |
| 2026-05-06 | Wells Fargo | maintain | Overweight | Overweight |
| 2026-05-06 | RBC Capital | maintain | Outperform | Outperform |
| 2026-03-23 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-20 | Citigroup | maintain | Buy | Buy |
| 2026-03-20 | B of A Securities | maintain | Buy | Buy |
| 2026-03-20 | Citizens | maintain | Market Outperform | Market Outperform |
| 2026-03-17 | Morgan Stanley | maintain | Overweight | Overweight |
| 2026-03-17 | RBC Capital | maintain | Outperform | Outperform |
| 2026-03-17 | Needham | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-0.74 | $541.0M | 8 |
| Sun Dec 31 | $2.34 | $873.2M | 9 |
| Mon Dec 31 | $6.42 | $1.31B | 3 |
| Tue Dec 31 | $10.31 | $1.81B | 3 |